Search Results
Prescient Therapeutics thrilled with additional Orphan Drug Designation status for PTX-100
Prescient Therapeutics PTX-100 continues to exhibit excellent safety profile
Prescient Therapeutics (ASX: PTX): PTX-100 targeted cell therapy briefing - 2 March 2023
Prescient Therapeutics (ASX: PTX) – Webinar Presentation
Prescient Therapeutics (ASX:PTX) | Webinar | 29/03/23
Prescient Therapeutics (ASX: PTX) Investor Briefing - 14 September 2022
Prescient Therapeutics (ASX: PTX) Investor Briefing - 28 July 2022
Prescient Therapeutics (ASX: PTX) Investor Briefing - 1 March 2022
Stocks of the Hour: Prescient Therapeutics, Lindian Resources, Solstice Minerals
ShareCafe 'Hidden Gems' Webinar - Prescient Therapeutics ASX:PTX
A diversified portfolio of cancer treatment medicines.
Talk 4: Foundations behind Prescient Design's approach to protein design (Kyunghyun Cho)
